Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone. [electronic resource]
Producer: 20191016Description: 3209-3217 p. digitalISSN:- 1433-7339
- Androstenes -- adverse effects
- Anticoagulants -- adverse effects
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Disease Progression
- Drug Interactions
- Humans
- Male
- Prednisone -- therapeutic use
- Prostatic Neoplasms, Castration-Resistant -- blood
- Quality of Life
- Retrospective Studies
- Thrombosis -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.